IRIS
FALCIANI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.354
EU - Europa 7.649
AS - Asia 3.782
SA - Sud America 635
AF - Africa 188
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.223
GB - Regno Unito 1.639
RU - Federazione Russa 1.473
CN - Cina 1.362
IT - Italia 1.321
SG - Singapore 1.060
IE - Irlanda 875
SE - Svezia 535
BR - Brasile 505
UA - Ucraina 449
DE - Germania 436
VN - Vietnam 391
FR - Francia 348
HK - Hong Kong 287
KR - Corea 213
FI - Finlandia 203
IN - India 122
ZA - Sudafrica 107
ES - Italia 90
BD - Bangladesh 74
CA - Canada 72
PL - Polonia 60
BE - Belgio 54
AR - Argentina 45
NL - Olanda 43
PK - Pakistan 36
TR - Turchia 33
JP - Giappone 32
MX - Messico 31
IR - Iran 25
AT - Austria 22
CZ - Repubblica Ceca 21
VE - Venezuela 18
EC - Ecuador 17
NG - Nigeria 17
CL - Cile 16
IQ - Iraq 16
CH - Svizzera 15
KE - Kenya 15
AU - Australia 14
AZ - Azerbaigian 12
ID - Indonesia 12
PH - Filippine 12
UZ - Uzbekistan 12
LT - Lituania 11
CO - Colombia 10
IL - Israele 10
KZ - Kazakistan 10
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
SA - Arabia Saudita 8
CI - Costa d'Avorio 6
DK - Danimarca 6
EU - Europa 6
PY - Paraguay 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NP - Nepal 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
CR - Costa Rica 3
GY - Guiana 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
SI - Slovenia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
GR - Grecia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
AO - Angola 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
LK - Sri Lanka 1
Totale 20.619
Salva come PNG Salva come JPEG
Città #
Southend 1.445
Dallas 982
Dublin 866
Fairfield 662
Ashburn 622
Singapore 581
Chandler 481
Moscow 421
Siena 419
Jacksonville 365
San Jose 365
Santa Clara 364
Beijing 346
Woodbridge 341
Ann Arbor 297
Houston 278
Wilmington 270
Seattle 268
Hong Kong 267
Hefei 263
Menlo Park 234
Cambridge 212
Seoul 209
Los Angeles 154
New York 143
Princeton 143
Milan 124
The Dalles 122
Council Bluffs 117
Nanjing 112
Florence 103
Johannesburg 100
Ho Chi Minh City 98
Helsinki 87
Munich 86
Lauterbourg 82
Dong Ket 81
Boardman 76
Hanoi 70
Rome 64
Málaga 60
Shanghai 59
San Mateo 54
Nanchang 49
Buffalo 48
São Paulo 47
San Diego 46
Fremont 40
London 39
Brussels 38
Orem 38
Bengaluru 36
Dearborn 34
Turku 32
Warsaw 32
Hebei 30
Shenyang 30
Brooklyn 28
Chicago 28
Redwood City 28
Tianjin 26
Montreal 25
Düsseldorf 24
Kunming 24
Columbus 23
Phoenix 23
Da Nang 22
Frankfurt am Main 22
Redondo Beach 22
Tokyo 22
Toronto 22
Washington 22
Bagno a Ripoli 21
Stockholm 20
Lappeenranta 19
Chennai 18
Porto Alegre 18
Abuja 17
Brno 17
Dhaka 17
Atlanta 16
Belo Horizonte 16
Denver 16
Jiaxing 16
Paris 16
Amsterdam 15
Changsha 15
Manchester 15
Nuremberg 15
Poplar 15
Rio de Janeiro 15
San Francisco 15
Gdansk 14
Vienna 14
Brasília 13
Hangzhou 13
Izmir 13
Kansas City 13
Ningbo 13
Zhengzhou 13
Totale 13.831
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 376
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 368
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 364
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 359
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 337
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 326
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 322
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 310
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 308
A new NT4 peptide-based drug delivery system for cancer treatment 304
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 303
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 303
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 302
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 301
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 295
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 288
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 288
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 287
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 280
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 278
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 276
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 274
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 274
Tumor imaging with tetrabranched neurotensin 268
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 264
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Branched peptides as bioactive molecules for drug design 262
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 259
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 259
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 256
Branched peptides for tumor diagnosis and therapy 249
Branched Neurotensin For Tumor Targeting 249
Exploration of novel thiobarbituric acid- rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors 245
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 244
Bioactive peptides from libraries 243
Nanoparticles exposing neurotensin tumor-specific drivers 241
Branched peptides as targeting agents for tumor imaging and therapy 240
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 233
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 231
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 229
Branched Neurotensin peptides for tumor personalized therapy 226
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 225
A Multidisciplinary Approach for the Identification ofNovel HIV-1 Non-Nucleoside Reverse TranscriptaseInhibitors: S-DABOCs and DAVPs 222
Branched multimeric peptides for tumor diagnosis and therapy 221
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 220
Synthetic peptides in the form of dendrimers become resistant to protease activity 220
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 219
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 218
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 214
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 213
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 210
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 210
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 209
The antimicrobial peptide M33. An example of drug development 209
The development of antimicrobial peptides as new antibacterial drugs 207
Branched neurotensin for tumor targeting 206
Tumor selective targeting by branched peptides 202
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 200
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 199
Molecular basis of branched peptides resistance to enzyme proteolysis 199
Are periodontitis and psoriasis associated? A pre-clinical murine model 196
Neurotensin-derived branched peptides and uses thereof 193
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 193
Branched peptides as therapeutics 191
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 187
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 182
Synthetic antidotes against snake neurotoxins 175
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 171
The antimicrobial peptide M33. An example of drug development 168
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 168
Branched neurotensin peptides for tumor targeting 163
Tumor imaging with tetrabranched neurotensin 162
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 161
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 160
Dendrimeric peptides for tumor targeting 158
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 157
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 157
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 155
Branched peptides as novel tumor-targeting agents for bladder cancer 153
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 146
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 144
Synthetic peptides in the form of dendrimers can become resistant to protease activity 141
Synthetic inhibitors of anthrax lethal toxin 139
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 138
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 138
Extracellular Vesicles of Pseudomonas: Friends and Foes 134
Structurally driven selection of human hepatitis C virus mimotopes. 126
Strong synthetic inhibitors of anthrax lethal toxin 120
Peptide Drugs 113
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 112
null 105
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 90
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 86
null 78
A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 77
Establishment and application of a vesicle extraction method for clinical strains of Pseudomonas aeruginosa 74
Establishment and application of a vesicle extraction method for clinical strains of Pseudomonas aeruginosa 15
SET-M33 peptide as a selective in vitro antimicrobial agent against the porcine respiratory pathogen Glaesserella parasuis 13
The Synergetic Effect of Periodontal Therapy and TNF-α Inhibitor for the Treatment of Comorbid Periodontitis and Psoriasis 12
Ex-vivo evaluation of intratubular antibacterial activity and biocompatibility of two hydraulic calcium silicate-based endodontic sealers 11
Totale 20.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 0 0 189
2021/20221.246 77 122 79 132 85 51 51 77 48 151 127 246
2022/20231.766 94 186 217 226 188 337 41 145 142 82 79 29
2023/20241.406 45 41 125 81 61 392 489 29 7 27 18 91
2024/20252.895 56 130 330 173 351 157 119 188 221 118 297 755
2025/20266.884 530 936 819 880 1.370 258 741 227 312 440 245 126
Totale 20.889